表纸
市场调查报告书

放射治疗的全球市场:各类型 、各产品 、各用途 (前列腺癌症,乳癌)、各终端用户的预测 (到2023年)

Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User - Forecasts to 2023

出版商 MarketsandMarkets 商品编码 344382
出版日期 内容资讯 英文 227 Pages
订单完成后即时交付
价格
Back to Top
放射治疗的全球市场:各类型 、各产品 、各用途 (前列腺癌症,乳癌)、各终端用户的预测 (到2023年) Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User - Forecasts to 2023
出版日期: 2019年01月10日内容资讯: 英文 227 Pages
简介

Title:
放射治疗的全球市场:各类型 (外部照射治疗 (IGRT,IMRT,3D-CRT,SRT)/内部照射治疗 (LDR,HDR)、各产品 (LINAC),电脑刀,伽马刀,影像导引断层式放射治疗,粒子线治疗,回旋加速器)、各用途 (前列腺癌症,乳癌)、各终端用户的预测 (到2023年)

全球放射治疗市场预测将从2017年的68亿1000万美元,到2022年扩大为94亿7000万美元。市场在2017年~2022年以间,预计将以年复合成长率 (CAGR) 6.8%的速度成长。

本报告提供全球放射治疗市场相关调查分析,市场概要,产业趋势,各市场区隔的市场分析,竞争情形,主要企业等相关的系统性资讯。

FIGURE 14 RADIOTHERAPY MARKET

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 重要考察

  • 放射治疗:市场概要
  • 各地区分析:各放射治疗市场,类型
  • 放射治疗市场规模:各产品
  • 放射治疗市场:各用途
  • 放射治疗市场各地区概述

第5章 市场概要

  • 简介
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
    • 产业趋势

第6章 放射治疗的全球市场:各产品类型

  • 简介
  • 外部照射治疗
  • 内部照射治疗
  • 全身性放射照射治疗

第7章 放射治疗的全球市场:各类型

  • 简介
  • 外部照射治疗
  • 内部照射治疗
  • 全身性放射照射治疗

第8章 放射治疗的全球市场:各用途

  • 简介
  • 外部照射治疗
  • 内部照射治疗

第9章 放射治疗的全球市场:各终端用户

  • 简介
    • 医院
    • 癌症研究机关
    • 门诊病人、放射治疗中心

第10章 放射治疗的全球市场:各地区

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 其他

第11章 竞争情形

  • 概要
  • 选择供应商标准
  • 竞争领导制图
  • 竞争基准

第12章 企业简介

  • VARIAN MEDICAL SYSTEMS, INC.
  • ELEKTA AB
  • ACCURAY INCORPORATED
  • IBA (ION BEAM APPLICATIONS SA)
  • NORDION, INC.
  • C. R. BARD, INC.
  • ISORAY MEDICAL, INC.
  • RAYSEARCH LABORATORIES
  • 三菱电机
  • MEVION MEDICAL SYSTEMS, INC.
  • THERAGENICS CORPORATION
  • P-CURE LTD.
  • VIEWRAY INC.
  • PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
  • PRONOVA SOLUTIONS, LLC.

第13章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: MD 1773

"The radiotherapy market is projected to grow at a CAGR of 4.1% during the forecast period"

The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number of radiotherapy centers worldwide. However, the underdeveloped public health infrastructure in emerging countries, shortage of trained and skilled radiation oncologists, and the limited access to and affordability of various radiotherapy treatment options are the major factors that are expected to restrain the growth of this market during the forecast period.

"The linear accelerators segment is expected to account for the largest market share during the forecast period"

Based on product type, the external beam radiotherapy products market is segmented into linear accelerators (LINAC), particle therapy systems, and conventional cobalt-60 teletherapy units. The linear accelerators segment is expected to account for the largest share of this market in 2018, driven by the development of advanced systems and their growing adoption across the globe.

"The seeds segment is expected to hold the largest share of the internal beam radiotherapy/brachytherapy products market during the forecast period"

Based on product type, the internal beam radiotherapy/brachytherapy products market is segmented into seeds, applicators, afterloaders, and electronic brachytherapy products. The seeds segment is expected to account for the largest share of this market in 2018. The large share of this segment can be attributed to the growing availability of seeds; advances in patient selection, treatment planning, technique, and technology; and growing applications in prostate cancer treatment.

"Europe to account for the second-largest share of the global market in 2018"

The radiotherapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global radiotherapy market in 2018. The growing incidence of cancer, supportive government initiatives, and the implementation of radiotherapy training programs & conferences/symposiums are the major factors propelling the demand for radiotherapy products in Europe. Furthermore, several key market players are focusing on enhancing their radiotherapy products to improve the quality of patient care across Europe.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (35%), Europe (26%), APAC (23%), and RoW (16%)

The major players in the market include: Varian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US), among others.

Research Coverage:

This report studies the radiotherapy market based on type, product type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Reasons to Buy the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the radiotherapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2. PRIMARY RESEARCH VALIDATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH LIMITATIONS AND ASSUMPTIONS
    • 2.4.1. LIMITATIONS
    • 2.4.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. RADIOTHERAPY MARKET OVERVIEW
  • 4.2. EUROPE: EXTERNAL RADIOTHERAPY MARKET, BY TYPE, 2018
  • 4.3. INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE
  • 4.4. EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION
  • 4.5. REGIONAL ANALYSIS: RADIOTHERAPY MARKET, BY END USER
  • 4.6. RADIOTHERAPY MARKET, BY COUNTRY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements
      • 5.2.1.2. Rising prevalence of cancer
      • 5.2.1.3. Increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy
      • 5.2.1.4. Growing use of particle therapy for cancer treatment
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of adequate healthcare infrastructure
      • 5.2.2.2. Shortage of trained personnel
      • 5.2.2.3. Affordability and accessibility of treatment
      • 5.2.2.4. Complex nature of radiotherapy
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Growing government and private investments to meet the increasing demand for cancer treatment
      • 5.2.3.3. Improving reimbursement scenario
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Difficulties in visualizing tumors during radiotherapy procedures
      • 5.2.4.2. Risk of radiation exposure
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. GROWING ADOPTION OF PENCIL-BEAM SCANNING
    • 5.3.2. GROWING NUMBER OF COLLABORATIONS AND ACQUISITIONS

6. RADIOTHERAPY MARKET, BY PRODUCT TYPE

  • 6.1. INTRODUCTION
  • 6.2. EXTERNAL BEAM RADIOTHERAPY
    • 6.2.1. LINEAR ACCELERATORS
      • 6.2.1.1. Conventional Linear Accelerators
        • 6.2.1.1.1. Lower equipment and maintenance cost will drive the market for conventional LINACs
      • 6.2.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
        • 6.2.1.2.1. Automation and real-time tracking features have ensured demand for stereotactic advanced LINAC
        • 6.2.1.2.2. Gamma Knife
        • 6.2.1.2.2.1. The Gamma Knife system is considered a gold standard for brain tumor treatment
        • 6.2.1.2.3. CyberKnife
        • 6.2.1.2.3.1. CyberKnife offers a precise radiation delivery method with specialized tracking and robotic correction capabilities
        • 6.2.1.2.4. TomoTherapy
        • 6.2.1.2.4.1. 360-degree (helical) radiation treatment with TomoTherapy is adding growth opportunities to this segment
    • 6.2.2. PARTICLE THERAPY SYSTEMS
      • 6.2.2.1. Cyclotrons
        • 6.2.2.1.1. Leading players in the particle therapy market mainly manufacture cyclotrons
      • 6.2.2.2. Synchrotrons
        • 6.2.2.2.1. Increasing investment for the development of synchrotron facilities are contributing to market growth
      • 6.2.2.3. Synchrocyclotrons
        • 6.2.2.3.1. High space requirements of synchrocyclotrons are limiting its widespread adoption
    • 6.2.3. CONVENTIONAL COBALT-60 TELETHERAPY UNITS
      • 6.2.3.1. High cost and risk of radiation exposure with cobalt-60 radioisotopes have hindered the growth of this segment
  • 6.3. INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    • 6.3.1. SEEDS
      • 6.3.1.1. Adverse side-effects associated with seeds limit their adoption
    • 6.3.2. APPLICATORS
      • 6.3.2.1. Manual applicators pose a high risk of radiation exposure to the patients and staff
    • 6.3.3. AFTERLOADERS
      • 6.3.3.1. Modern afterloaders offer proper positioning and better control of isotopes inside the patient body
    • 6.3.4. ELECTRONIC BRACHYTHERAPY PRODUCTS
      • 6.3.4.1. Electronic brachytherapy requires low amount of shielding than alternatives
  • 6.4. SYSTEMIC RADIOTHERAPY
    • 6.4.1. IOBENGUANE (I-131)
      • 6.4.1.1. Increasing incidence of thyroid cancer is driving the growth of this segment
    • 6.4.2. SAMARIUM-153
      • 6.4.2.1. Samarium-153 has wide applications for bone metastasis
    • 6.4.3. RHENIUM-186
      • 6.4.3.1. Lack of insurance coverage with the use of Rhenium-186 restricting its growth
    • 6.4.4. OTHER SYSTEMIC RADIOTHERAPY PRODUCTS

7. RADIOTHERAPY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. EXTERNAL BEAM RADIOTHERAPY
    • 7.2.1. IMAGE-GUIDED RADIOTHERAPY
      • 7.2.1.1. Image-guided radiotherapy is widely used to the treatment of deep-seated tumors
    • 7.2.2. 3D CONFORMAL RADIOTHERAPY
      • 7.2.2.1. Multiple beams with 3D-CRT allow precise radiation conforming to the tumor size and shape
    • 7.2.3. INTENSITY-MODULATED RADIOTHERAPY
      • 7.2.3.1. Volumetric Arc Therapy
        • 7.2.3.1.1. Advancements in the VMAT technology driving its widespread adoption
      • 7.2.3.2. TomoTherapy
        • 7.2.3.2.1. Minimal exposure to normal tissues - A major advantage of TomoTherapy
    • 7.2.4. STEREOTACTIC THERAPY
      • 7.2.4.1. Stereotactic therapy offers a minimally invasive alternative to ablation surgeries
    • 7.2.5. PARTICLE THERAPY
      • 7.2.5.1. Particle therapy is increasingly being adopted as a primary mode of treatment for various cancer types
  • 7.3. INTERNAL BEAM RADIOTHERAPY
    • 7.3.1. LOW-DOSE-RATE BRACHYTHERAPY
      • 7.3.1.1. Lower risk of radiation exposure to the surrounding tissues with LDR supporting market growth
    • 7.3.2. HIGH-DOSE-RATE BRACHYTHERAPY
      • 7.3.2.1. Better patient care with HDR is driving its widespread adoption
    • 7.3.3. PULSED-DOSE-RATE BRACHYTHERAPY
      • 7.3.3.1. Pulsed-dose rate brachytherapy combines the advantages of HDR and LDR brachytherapy
  • 7.4. SYSTEMIC RADIOTHERAPY
    • 7.4.1. INTRAVENOUS RADIOTHERAPY
      • 7.4.1.1. Intravenous route of brachytherapy results in maximum bioavailability
    • 7.4.2. ORAL RADIOTHERAPY
      • 7.4.2.1. Longer distribution time associated with the oral mode of radiation delivery limiting its demand
    • 7.4.3. INSTILLATION RADIOTHERAPY
      • 7.4.3.1. Lesser localization with instillation brachytherapy is limiting its widespread adoption

8. RADIOTHERAPY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. EXTERNAL BEAM RADIATION THERAPY
    • 8.2.1. PROSTATE CANCER
      • 8.2.1.1. High incidence of prostate cancer will drive the demand for EBRT
    • 8.2.2. BREAST CANCER
      • 8.2.2.1. Adoption of advanced EBRT systems and increasing research will drive market growth
    • 8.2.3. LUNG CANCER
      • 8.2.3.1. Radiotherapy can be used as solo or combination therapy for lung cancer
    • 8.2.4. HEAD AND NECK CANCER
      • 8.2.4.1. Benefits of external radiotherapy will support its use in head and neck cancer treatment
    • 8.2.5. COLORECTAL CANCER
      • 8.2.5.1. Availability of alternative therapeutic options limits the growth of this segment
    • 8.2.6. OTHER CANCERS
  • 8.3. INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    • 8.3.1. PROSTATE CANCER
      • 8.3.1.1. Rapidity and precision of brachytherapy in prostate cancer treatment have driven market growth
    • 8.3.2. GYNECOLOGICAL CANCER
      • 8.3.2.1. Availability of alternatives hinders the adoption of brachytherapy in gynecological cancer treatment
    • 8.3.3. BREAST CANCER
      • 8.3.3.1. Precision and rapid treatment times are driving the use of brachytherapy in breast cancer applications
    • 8.3.4. CERVICAL CANCER
      • 8.3.4.1. A combination of brachytherapy and chemotherapy is typically used for cervical cancer treatment
    • 8.3.5. PENILE CANCER
      • 8.3.5.1. Advantages of brachytherapy in penile cancer treatment have driven its adoption
    • 8.3.6. OTHER CANCERS

9. RADIOTHERAPY MARKET, BY END USER

  • 9.1. INTRODUCTION
    • 9.1.1. HOSPITALS
      • 9.1.1.1. Increasing number of small-footprint advanced radiotherapy products promoting their adoption in hospitals
    • 9.1.2. INDEPENDENT RADIOTHERAPY CENTERS
      • 9.1.2.1. Rising consolidation of healthcare networks is challenging the growth of freestanding radiotherapy centers

10. RADIOTHERAPY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Growing government initiatives boosting the adoption of radiotherapy in the US
    • 10.2.2. CANADA
      • 10.2.2.1. Rising cancer incidence driving the demand for radiotherapy in Canada
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Increasing awareness of novel and advanced radiotherapy products a key factor contributing to market growth
    • 10.3.2. FRANCE
      • 10.3.2.1. Growing government initiatives boosting the adoption of radiotherapy in France
    • 10.3.3. UK
      • 10.3.3.1. Leading market players focusing on expanding their product offerings in the UK
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. Presence of a large number of local manufactures supporting the growth of the radiotherapy market in China
    • 10.4.2. JAPAN
      • 10.4.2.1. Rising prevalence of cancer is driving the adoption of radiotherapy in Japan
    • 10.4.3. INDIA
      • 10.4.3.1. Shortage of skilled radiotherapy professionals in India is restraining market growth
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 11.3.2. ACQUISITIONS
    • 11.3.3. EXPANSIONS
    • 11.3.4. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  • 11.4. VENDOR DIVE OVERVIEW
  • 11.5. VENDOR INCLUSION CRITERIA
  • 11.6. VENDOR DIVE
    • 11.6.1. VANGUARDS
    • 11.6.2. INNOVATORS
    • 11.6.3. DYNAMIC PLAYERS
    • 11.6.4. EMERGING COMPANIES

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. ACCURAY INCORPORATED
  • 12.2. C. R. BARD, INC.
  • 12.3. ELEKTA
  • 12.4. HITACHI, LTD.
  • 12.5. IBA (ION BEAM APPLICATIONS SA)
  • 12.6. ISORAY MEDICAL, INC.
  • 12.7. MEVION MEDICAL SYSTEMS, INC.
  • 12.8. OPTIVUS PROTON THERAPY, INC.
  • 12.9. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
  • 12.10. P-CURE LTD.
  • 12.11. PROVISION HEALTHCARE, LLC.
  • 12.12. SUMITOMO HEAVY INDUSTRIES, LTD
  • 12.13. THERAGENICS CORPORATION
  • 12.14. VARIAN MEDICAL SYSTEMS, INC.
  • 12.15. VIEWRAY INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NATIONAL AVERAGE MEDICARE REIMBURSEMENT: OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) ESTIMATED PER COURSE
  • TABLE 2: RADIOTHERAPY MARKET, BY PRODUCT TYPE, 2016-2023 (USD MILLION)
  • TABLE 3: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE, 2016-2023 (USD MILLION)
  • TABLE 4: EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: EXTERNAL BEAM RADIOTHERAPY MARKET FOR LINEAR ACCELERATORS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 6: EXTERNAL BEAM RADIOTHERAPY MARKET FOR LINEAR ACCELERATORS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINAC MARKET, BY PRODUCT TYPE, 2016-2023 (USD MILLION)
  • TABLE 9: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: GAMMA KNIFE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: CYBERKNIFE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: TOMOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: EXTERNAL BEAM RADIOTHERAPY MARKET FOR PARTICLE THERAPY SYSTEMS, BY PRODUCT TYPE, 2016-2023 (USD MILLION)
  • TABLE 14: EXTERNAL BEAM RADIOTHERAPY MARKET FOR PARTICLE THERAPY SYSTEMS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: PARTICLE THERAPY SYSTEMS MARKET FOR CYCLOTRONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: PARTICLE THERAPY SYSTEMS MARKET FOR SYNCHROTRONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: PARTICLE THERAPY SYSTEMS MARKET FOR SYNCHROCYCLOTRONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: EXTERNAL BEAM RADIOTHERAPY MARKET FOR CONVENTIONAL COBALT-60 TELETHERAPY UNITS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2016-2023 (USD MILLION)
  • TABLE 20: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR SEEDS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR APPLICATORS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR AFTERLOADERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR ELECTRONIC BRACHYTHERAPY PRODUCTS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 26: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 27: EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 30: INTENSITY-MODULATED RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 31: INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: VOLUMETRIC ARC THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: TOMOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: STEREOTACTIC THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: PARTICLE THERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 36: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 38: LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 40: PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 41: RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 44: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR LUNG CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 46: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR HEAD AND NECK CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR COLORECTAL CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 48: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR OTHER CANCERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 49: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 51: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 53: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR CERVICAL CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PENILE CANCER, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 55: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR OTHER CANCERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: RADIOTHERAPY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 58: RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 59: RADIOTHERAPY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: NORTH AMERICA: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 63: NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 64: NORTH AMERICA: STEREOTACTIC ADVANCED LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: NORTH AMERICA: INTENSITY-MODULATED RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 73: US: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 75: US: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 77: CANADA: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 79: CANADA: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 81: EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 82: EUROPE: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 84: EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: EUROPE: STEREOTACTIC ADVANCED LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 88: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: RADIOTHERAPY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 94: GERMANY: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 95: GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 96: GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 98: FRANCE: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 100: FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 102: UK: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 104: UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 106: REST OF EUROPE: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 108: REST OF EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 111: ASIA PACIFIC: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 113: ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 114: ASIA PACIFIC: STEREOTACTIC ADVANCED LINEAR ACCELERATORS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 115: ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 116: ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 117: ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: APAC: INTENSITY-MODULATED RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 123: CHINA: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 124: CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 125: CHINA: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 126: CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 127: JAPAN: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 129: JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 131: INDIA: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 133: INDIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 134: INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 135: ROAPAC: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 136: ROAPAC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 137: ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 139: ROW: RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: ROW: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 141: ROW: LINEAR ACCELERATORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: ROW: STEREOTACTIC ADVANCED LINEAR ACCELERATORS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 143: ROW: PARTICLE THERAPY SYSTEMS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 144: ROW: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 145: ROW: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 146: ROW: INTENSITY-MODULATED RADIOTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 147: ROW: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: ROW: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: ROW: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: ROW: RADIOTHERAPY MARKET, BY END USER, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RADIOTHERAPY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARIES: GLOBAL RADIOTHERAPY MARKET
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: RADIOTHERAPY MARKET, BY TYPE, 2018 (USD MILLION)
  • FIGURE 9: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: EXTERNAL BEAM RADIOTHERAPY MARKET SHARE, BY APPLICATION, 2018 VS. 2023
  • FIGURE 12: RADIOTHERAPY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 13: RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 14: RISING CANCER PREVALENCE ACROSS THE GLOBE IS DRIVING GROWTH IN THE RADIOTHERAPY MARKET
  • FIGURE 15: IMAGE-GUIDED RADIOTHERAPY TO DOMINATE THE EXTERNAL BEAM RADIOTHERAPY MARKET IN EUROPE IN 2018
  • FIGURE 16: AFTERLOADERS TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: OTHERS CANCER APPLICATION SEGMENT TO GROW AT THE FASTEST RATE IN THE EXTERNAL BEAM RADIOTHERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE RADIOTHERAPY END USER MARKET IN 2018
  • FIGURE 19: CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 20: RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21: INCIDENCE OF CANCER, BY REGION, 2012-2020 (THOUSAND)
  • FIGURE 22: PARTICLE THERAPY SYSTEMS TO REGISTER HIGHEST GROWTH IN THE EXTERNAL BEAM RADIOTHERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: SEEDS TO DOMINATE INTERNAL BEAM RADIOTHERAPY MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: IMAGE-GUIDED RADIOTHERAPY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EXTERNAL BEAM RADIOTHERAPY MARKET IN 2018
  • FIGURE 25: NUMBER OF PARTICLE THERAPY FACILITIES PRESENT (AS OF OCTOBER 2018) & UNDER CONSTRUCTION ACROSS THE GLOBE
  • FIGURE 26: HIGH-DOSE-RATE BRACHYTHERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE INTERNAL BEAM RADIOTHERAPY MARKET IN 2018
  • FIGURE 27: PROSTATE CANCER TO DOMINATE THE EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: BREAST CANCER TO REGISTER HIGHEST GROWTH IN INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET
  • FIGURE 29: HOSPITALS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 31: EUROPE: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 32: ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 33: ROW: RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 34: KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET BETWEEN 2015-2018
  • FIGURE 35: RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 36: COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
  • FIGURE 37: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
  • FIGURE 38: ACCURAY INCORPORATED: COMPANY SNAPSHOT (2018)
  • FIGURE 39: C. R. BARD, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 40: ELEKTA AB: COMPANY SNAPSHOT (2017)
  • FIGURE 41: HITACHI: COMPANY SNAPSHOT (2017)
  • FIGURE 42: ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT (2017)
  • FIGURE 43: ISORAY MEDICAL, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 44: SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2016)
  • FIGURE 45: VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 46: VIEWRAY, INC.: COMPANY SNAPSHOT (2017)
Back to Top